【レポートの概要（一部）】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Breakthrough in COPD research
• COPD: An overview
PART 05: Pipeline analysis
PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 07: Key buying criteria for COPD drugs
PART 08: Market segmentation by drug class
• Combination therapies
• Bronchodilators
• Steroids
• Leukotriene antagonists
• PDE-4 inhibitors
• Other medications
PART 09: Segmentation by ROA
• Inhalation
• Oral
PART 10: Drug delivery devices market for COPD drugs
• Market overview
• Market segmentation by product type
PART 11: Geographical segmentation
• Global COPD drugs market by geography 2015-2020
• COPD drugs market in Americas
• COPD drugs market in EMEA
• COPD drugs market in APAC
• COPD drugs market in China
PART 12: Market drivers
• Increase in smoking prevalence
• Uptake of LABA/LAMA combination therapies
• Robust pipeline with tentative approval of drugs
PART 13: Impact of drivers
PART 14: Market challenges
• Lack of innovation in pipeline molecules
• Negligence toward use of controller medications
• Low diagnosis rates
PART 15: Impact of drivers and challenges
PART 16: Market trends
• Innovative technologies for drug delivery
• Increased adoption of e-cigarettes and smoking cessation products
• Emergence of ultrasonic nebulizers
• Increase in online marketing services
• Growing use of home healthcare devices
PART 17: Vendor landscape
• Competitive scenario
• Key news
PART 18: Key vendor analysis
• AstraZeneca
• Boehringer Ingelheim
• GSK
• Novartis
• Teva Pharmaceuticals
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Breakthrough research activities in field of COPD
Exhibit 03: Percentage share of pipeline molecules based on stage of development
Exhibit 04: Pipeline molecules based on MOA and stage of development
Exhibit 05: Percentage share of pipeline drugs based on MOA
Exhibit 06: Global COPD drugs market 2015-2020 ($ billions)
Exhibit 07: Global COPD drugs market snapshot: Developed and emerging markets 2015
Exhibit 08: Global COPD drugs market: Key parameters driving the market 2015
Exhibit 09: Five forces analysis
Exhibit 10: Key buying criteria for COPD drugs
Exhibit 11: Impact of key customer segments on global COPD drugs market
Exhibit 12: Segmentation of COPD drugs based on drug class
Exhibit 13: Percentage share of global COPD drugs by drug class based on revenue 2015
Exhibit 14: Global COPD drugs market: Drug class segmentation growth cycle analysis 2015
Exhibit 15: Combination therapies market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 16: Bronchodilators market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 17: Steroid drugs market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 18: Leukotriene antagonists market in global COPD drugs market 2015-2020 ($ billions)
Exhibit 19: YoY growth and revenue of Daliresp 2012-2015 ($ billions)
Exhibit 20: Global COPD drugs market segmentation by drug class 2015
Exhibit 21: Segmentation of global COPD drugs market by ROA
Exhibit 22: Global COPD drug delivery devices market 2015-2020 ($ millions)
Exhibit 23: Global COPD devices market segmentation by product type
Exhibit 24: Percentage share of global COPD drug delivery devices by type 2015
Exhibit 25: Percentage share of inhalers in global COPD drug delivery devices market 2015
Exhibit 26: Inhalers market in global COPD drug-devices market 2015-2020 ($ millions)
Exhibit 27: Percentage share of nebulizers in global COPD drug delivery devices market by technology 2015
Exhibit 28: Nebulizers market in global COPD drug-devices market 2015-2020 ($ millions)
Exhibit 29: Global COPD drugs market by geography 2015-2020
Exhibit 30: Percentage share of global COPD drugs market by geography 2015 and 2020
Exhibit 31: Global COPD drugs market segmentation by geography 2015-2020 ($ billions)
Exhibit 32: Global share of COPD drugs market by geography 2015
Exhibit 33: COPD drugs market in Americas 2015-2020 ($ billions)
Exhibit 34: Prevalence rates of COPD in few countries of EMEA
Exhibit 35: COPD drugs market in EMEA 2015-2020 ($ billions)
Exhibit 36: COPD drugs market in APAC 2015-2020 ($ billions)
Exhibit 37: COPD drugs market in China 2015-2020 ($ billions)
Exhibit 38: Global COPD drugs market: Country analysis based on revenue and growth rate
Exhibit 39: Drug approvals in COPD drugs market in past three years (2014-2016)
Exhibit 40: Few COPD drug molecules in registration stage
Exhibit 41: Impact of drivers
Exhibit 42: Controller and rescue medications for the treatment of COPD
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Key vendors ranking 2015
Exhibit 45: Market share of key vendors based on revenues 2015
Exhibit 46: Geographical presence of key vendors
Exhibit 47: Competitive scenario of global COPD drugs market vendors 2015-2020
Exhibit 48: AstraZeneca: YoY revenue and growth rate of Symbicort 2013-2015 ($ billions)
Exhibit 49: AstraZeneca: Geographical segmentation of Symbicort 2015
Exhibit 50: AstraZeneca: YoY revenue and growth rate of Pulmicort 2013-2015 ($ millions)
Exhibit 51: AstraZeneca: Geographical segmentation of Pulmicort 2015
Exhibit 52: AstraZeneca: Metrics analysis
Exhibit 53: Boehringer Ingelheim: YoY revenue and growth rate of Spiriva 2013-2015 ($ billions)
Exhibit 54: Boehringer Ingelheim: Metrics analysis
Exhibit 55: GSK: YoY revenue and growth rate of Seretide/Advair 2013-2015 ($ billions)
Exhibit 56: Geographical segmentation of Seretide/Advair 2015
Exhibit 57: GSK: YoY revenue and growth rate of Flixotide/Flovent 2013-2015 ($ billions)
Exhibit 58: GSK: Geographical segmentation of Flixotide/Flovent 2015
Exhibit 59: GSK: YoY revenue and growth rate of Ventolin 2013-2015 ($ billions)
Exhibit 60: GSK: Geographical segmentation of Ventolin 2015
Exhibit 61: GSK: YoY growth and revenue of Relvar/Breo Ellipta 2014-2015 ($ millions)
Exhibit 62: GSK: Geographical segmentation of Relvar/Breo Ellipta 2015
Exhibit 63: GSK: YoY growth and revenue of Anoro Ellipta 2014-2015 ($ millions)
Exhibit 64: GSK: Geographical segmentation of Anoro Ellipta 2015
Exhibit 65: GSK: Metrics analysis
Exhibit 66: Novartis: YoY revenue and growth rate of Onbrez Breezhaler/Arcapta Neohaler 2014-2015 ($ millions)
Exhibit 67: Novartis: YoY revenue and growth rate of Seebri Breezhaler 2013-2015 ($ millions)
Exhibit 68: Novartis: YoY revenue and growth rate of Ultibro Breezhaler 2013-2015 ($ millions)
Exhibit 69: Novartis: Metrics analysis
Exhibit 70: Teva Pharmaceuticals: YoY revenue and growth rate of ProAir 2013-2015 ($ millions)
Exhibit 71: Teva Pharmaceuticals: YoY revenue and growth rate of Qvar 2013-2015 ($ millions)
Exhibit 72: Teva Pharmaceuticals: Metrics analysis
【レポート販売概要】
■ タイトル：慢性閉塞性肺疾患（COPD）治療薬の世界市場2016-2020■ 英文：Global Chronic Obstructive Pulmonary Disease Drugs Market 2016-2020
■ 発行日：2016年7月20日
■ 調査会社：Technavio
■ 商品コード：IRTNTR9968
■ 調査対象地域：グローバル
- DRM（デジタル著作権管理）の世界市場予測The rapid development of Information and Communication Technology (ICT) and ICT-based business in the recent years, together with the advent of the internet has created electronic marketplaces with new technological, social, management, and organizational issues. Technological advancement has made it possible to digitize the information, enabling sharing of information across the globe. This abili …
- 産業用UPS（無停電電源装置）のグローバル市場（2014-2018）About Industrial UPS A UPS system is an electrical appliance used to provide power backup to a load during a power breakdown. These UPS systems provide instantaneous power backup by ensuring continuous power supply from energy stored in batteries. UPS systems are widely deployed for continuous power supply in various industries such as the Data Center and IT, Chemical, and Food Processing industri …
- ソルベントナフサ/light aromの世界市場Solvent naphtha (petroleum), light arom. (CAS 64742-94-5) Market Research Report 2014 presents comprehensive data on solvent naphtha (petroleum), light arom. markets globally and regionally (Europe, Asia, North America etc.) The report includes solvent naphtha (petroleum), light arom. description, covers its application areas and related patterns. It overviews solvent naphtha (petroleum), light ar …
- グローバル・コスメシューティカル市場動向（～2018）Cosmeceuticals have become the fastest growing segment of the Cosmetics and Personal Care Industry. These products are described as cosmetic products with drug-like benefits and are the recent addition to the Cosmetics Industry. With increasing fascination among people to look young and the global population’s increasing median age, the cosmeceuticals product market is growing at a significant rat …
- デスクトップ仮想化（VDI）の世界市場2017-2021About Virtual Desktop Infrastructure A virtual desktop infrastructure (VDI) solution can be considered a platform in which a client server is employed to access a user system virtually. This type of computing model makes use of a centralized storage space, where data and system applications are stored centrally on the server. End-users have to enter their login details to gain remote access to the …
- 世界の硫化染料市場2015The Global Sulfur Dyes Industry Report 2015 is a professional and in-depth study on the current state of the Sulfur Dyes industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Sulfur Dyes market analysis is provided for the international markets including development trends, competitive landscape analysis …
- パン類包装の世界市場2016-2020About Bakery Packaging The bakery sector holds a large share in the global food packaging market. Bakery products need to be packed in durable materials to reach customers fresh. Containers such as boxes, bags, and tubs are used to package these products. Vendors in the global bakery packaging market are continuously introducing packaging materials that can prevent contamination and better ensure …
- 世界の動物飼料用酸化防止剤（Animal Feed Antioxidants）市場動向（2012-2016）TechNavio's analysts forecast the Global Animal Feed Antioxidants market to grow at a CAGR of 5.07 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing concern about animal health and feed safety. The Global Animal Feed Antioxidants market has also been witnessing an increasing demand for natural antioxidants. However, the impact of global …
- 苛性ソーダの世界市場The global caustic soda market is estimated to grow at a CAGR of 6.7% from 2014 to 2019. Asia-Pacific contributed a share of 52.0% to the global caustic soda market in 2014 and is projected to grow at the highest CAGR of 7.1%. In this report, the global caustic soda market has been broadly classified on the basis of application and geography. The application segment is further classified into food …
- 農業用微量栄養素の世界市場：亜鉛、マンガン、ホウ素、銅、モリブデン、鉄The agricultural micronutrients market has grown exponentially in the last few years and this trend is projected to continue. The market was estimated at $4.8 billion in 2014 and is projected to grow at a CAGR of 8.1% from 2015 to 2020; the market is projected to reach $7.6 billion by 2020. The market is primarily driven by the increasing demand for food in tandem with the growing disposable incom …
- 自動車用イーサネット の世界市場2017-2021About Automotive Ethernet Ethernet is a technology that is commonly used in networking of computers and other connectivity enabling devices. It is most commonly used in local area network (LAN) and metropolitan area network (MAN). It was first introduced in 1973 and was standardized as IEEE 802.3 standard in 1983. Technavio’s analysts forecast the global automotive Ethernet market to grow at a CAG …
- 肝腎症候群(Hepatorenal Syndrome)：世界の治験レビュー（2015年上半期版）Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Hepatorenal Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Hepatorenal Syndrome clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hepatorenal Syndrome. It includes an overview of the trial numbers and their r …
- 麻酔気化器の世界市場2016-2020About Anesthesia Delivery System An anesthesia delivery system, which includes anesthesia machine and a breathing circuit, supports in pain management just before the surgical (pre-surgical) procedure. The anesthesia machine includes an anesthesia vaporizer, where the vaporizer mixes both anesthetic agent and oxygen together and delivers to the individual during the pre-surgical procedure through …
- オーガニックタンポンの世界市場2018-2022About Organic Tampons Tampons refer to a type of feminine hygiene products used by women during menstrual cycles. Organic tampons are generally made of organic or unbleached cotton and are free of chemicals. Technavio’s analysts forecast the global organic tampons market to grow at a CAGR of 6.82% during the period 2018-2022. Covered in this report The report covers the present scenario and the gr …
- Acute Renal Failure (ARF) (Acute Kidney Injury)：グローバル臨床試験レビューH2, 2013Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H2, 2013" provides data on the Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial scenario. This report provides elemental information and data relating to the clinical trials …
